Varying presentations in patients with symptomatic type IV vascular Ehlers-Danlos syndrome

Vascular and Endovascular Surgery

Volumn 46, Issue 2, 2012, Pages 163-166

  Dwivedi, Amit J ^a   Hamdallah, Omar ^a   Morris, Marvin E ^a   Yancey, Andrea E ^a   Ross, Charles B ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

connective tissue; Ehlers Danlos syndrome; vascular

Indexed keywords

ADULT; ARTERY DISSECTION; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CLINICAL FEATURE; EHLERS DANLOS SYNDROME; HUMAN; MALE; MEDICAL DECISION MAKING; ONSET AGE; SURGICAL RISK; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR DISEASE;

ADULT; ANEURYSM, DISSECTING; ANEURYSM, RUPTURED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CAROTID STENOSIS; EHLERS-DANLOS SYNDROME; FATAL OUTCOME; HUMANS; ILIAC ANEURYSM; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 84858402307     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574411433298     Document Type: Article

References (17)

1. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ.. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet. 1998 ; 77 (1). 31-37 (Pubitemid 28176360)
2. Pope FM, Nicholls AC, Jones PM, Wells RS, Lawrence D.. EDS IV (acrogeria): new autosomal dominant and recessive types. J R Soc Med. 1980 ; 73 (3). 180-186 (Pubitemid 10000165)
3. Ehlers E.. Cutis laxa, neigung zu haemorrhagien in der haut, lockerung mehrerer artikulationen. Dermatol Z. 1901 ; 8: 173-175
4. Danlos M.. Un cas de cutis laxa avec tumeurs par contusion chronique des coudes et des genoux. Bull Soc Derm Syph. 1908 ; 19: 70-72
5. Kitsiou-Tzeli S, Leze E, Salavoura K, et al. Long term follow up of a woman with classic form of Ehlers-Danlos syndrome associated with rare manifestations and review of the literature. Genet Couns. 2010 ; 21 (1). 75-83
6. Brooke BS, Arnaoutakis G, McDonnell NB, Black JH 3rd.. Contemporary management of vascular complications associated with Ehlers-Danlos syndrome. J Vasc Surg. 2010 ; 51 (1). 131-138
7. Parapia LA, Jackson C.. Ehlers-Danlos syndrome-a historical review. Br J Haematol. 2008 ; 141: 32-35
8. Barabas AP.. Heterogeneity of the Ehlers-Danlos syndrome: description of three clinical types and a hypothesis to explain the basic defect. BMJ. 1967 ; 2 (5552). 612-613
9. Barabas AP.. Vascular complications in the Ehlers-Danlos syndrome, with especial reference to the "arterial type" or Sack's syndrome. J Cardiovasc Surg. 1972 ; 13 (2). 160-167
10. Pepin M, Schwarze U, Superti-Furga A, Byers PH.. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000 ; 342 (10). 673-680 (Pubitemid 30131419)
11. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. Vasc Surg. 2005 ; 42 (1). 98-106 (Pubitemid 40966082)
12. Germain DP.. Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg. 2002 ; 16 (3). 391-397 (Pubitemid 34761176)
13. Byers PH.. Ehlers-Danlos syndrome: recent advances and current understanding of the clinical and genetic heterogeneity. J Invest Dermatol. 1994 ; 103 (5 suppl). 47S - 52S (Pubitemid 24348774)
14. Pyeritz RE.. Ehlers-Danlos syndrome (editorial). N Eng J Med. 2000 ; 342 (10). 730-732
15. Mitchell AL, Schwarze U, Jennings JF, Byers PH.. Molecular mechanisms of classical Ehlers-Danlos syndrome (EDS). Hum Mutat. 2009 ; 30 (6). 995-1002
16. Bergqvist D.. Ehlers-Danlos type IV syndrome: a review from a vascular surgical point of view. Eur J Surg. 1996 ; 162 (3). 163-170
17. Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010 ; 376 (9751). 1476-1484